share_log
Breakings ·  Oct 22 20:06
Sangamo Therapeutics: Potential Biologics License Application Submission Expected in H2 of 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment